Cargando…

COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews

People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by p...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Olivia, Dietze, Paul M., Maher, Lisa, Crawford, Sione, Peacock, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111623/
https://www.ncbi.nlm.nih.gov/pubmed/35184346
http://dx.doi.org/10.1111/dar.13448
_version_ 1784709292036718592
author Price, Olivia
Dietze, Paul M.
Maher, Lisa
Crawford, Sione
Peacock, Amy
author_facet Price, Olivia
Dietze, Paul M.
Maher, Lisa
Crawford, Sione
Peacock, Amy
author_sort Price, Olivia
collection PubMed
description People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by presenting vaccine intention data from Illicit Drug Reporting System interviews conducted in June–July 2021, in the early stages of vaccine rollout, with people in Australia who inject drugs (N = 888). Half the sample (48%, n = 419) reported that they were hesitant to receive the COVID‐19 vaccine, with key barriers relating to vaccine safety and side effect concerns. This level of hesitancy is substantially higher than that of the general population at a similar time. While we note that the subsequent Delta variant‐driven third wave of cases in Australia and efforts to increase population vaccination coverage may have altered intent in this group, this level of hesitancy warrants a targeted strategy to mitigate vaccine‐related concerns and maximise uptake. Ideally, this should comprise an inclusive health response that is peer‐led, with peer‐based organisations ideally positioned to direct immunisation service delivery and provide vaccine‐related messaging.
format Online
Article
Text
id pubmed-9111623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-91116232022-05-17 COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews Price, Olivia Dietze, Paul M. Maher, Lisa Crawford, Sione Peacock, Amy Drug Alcohol Rev Commentaries People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by presenting vaccine intention data from Illicit Drug Reporting System interviews conducted in June–July 2021, in the early stages of vaccine rollout, with people in Australia who inject drugs (N = 888). Half the sample (48%, n = 419) reported that they were hesitant to receive the COVID‐19 vaccine, with key barriers relating to vaccine safety and side effect concerns. This level of hesitancy is substantially higher than that of the general population at a similar time. While we note that the subsequent Delta variant‐driven third wave of cases in Australia and efforts to increase population vaccination coverage may have altered intent in this group, this level of hesitancy warrants a targeted strategy to mitigate vaccine‐related concerns and maximise uptake. Ideally, this should comprise an inclusive health response that is peer‐led, with peer‐based organisations ideally positioned to direct immunisation service delivery and provide vaccine‐related messaging. John Wiley & Sons Australia, Ltd 2022-02-20 2022-07 /pmc/articles/PMC9111623/ /pubmed/35184346 http://dx.doi.org/10.1111/dar.13448 Text en © 2022 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentaries
Price, Olivia
Dietze, Paul M.
Maher, Lisa
Crawford, Sione
Peacock, Amy
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title_full COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title_fullStr COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title_full_unstemmed COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title_short COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
title_sort covid‐19 vaccine acceptability among people in australia who inject drugs: update from the 2021 illicit drug reporting system interviews
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111623/
https://www.ncbi.nlm.nih.gov/pubmed/35184346
http://dx.doi.org/10.1111/dar.13448
work_keys_str_mv AT priceolivia covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews
AT dietzepaulm covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews
AT maherlisa covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews
AT crawfordsione covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews
AT peacockamy covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews